Novel zebrafish model reveals a critical role for MAPK in lymphangiogenesis

Journal of Pediatric Surgery

Volumn 47, Issue 1, 2012, Pages 177-182

  Fevurly, R Dawn ^a   Hasso, Sean ^a   Fye, Alexander ^a   Fishman, Steven J ^a   Chan, Joanne ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Lymphangiogenesis; Lymphatic disorders; MEK inhibitor; Primary lymphedema; VEGF; VEGF receptors

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; VASCULOTROPIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; ENZYME INHIBITION; IN VIVO STUDY; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM DISEASE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THORACIC DUCT; TRANSGENIC ANIMAL; ZEBRA FISH;

ANIMALS; DISEASE MODELS, ANIMAL; LYMPHANGIOGENESIS; MAP KINASE SIGNALING SYSTEM; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; ZEBRAFISH;

EID: 84855823543     PISSN: 00223468     EISSN: 15315037     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2011.10.035     Document Type: Article

References (38)

1. F. Bahram, and L. Claesson-Welsh VEGF-mediated signal transduction in lymphatic endothelial cells Pathophysiology 17 2010 253 261
2. T. Karpanen, and K. Alitalo Molecular biology and pathology of lymphangiogenesis Annu Rev Pathol 3 2008 367 397 (Pubitemid 351488286)
3. Y. Wang, and G. Oliver Current views on the function of the lymphatic vasculature in health and disease Genes Dev 24 2010 2115 2126
4. R.H. Adams, and K. Alitalo Molecular regulation of angiogenesis and lymphangiogenesis Nat Rev Mol Cell Biol 8 2007 464 478 (Pubitemid 46823443)
5. T. Takahashi, S. Yamaguchi, and K. Chida A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells EMBO J 20 2001 2768 2778 (Pubitemid 32938560)
6. T. Makinen, T. Veikkola, and S. Mustjoki Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3 EMBO J 20 2001 4762 4773 (Pubitemid 32848629)
7. S. Isogai, J. Hitomi, and K. Yaniv Zebrafish as a new animal model to study lymphangiogenesis Anat Sci Int 84 2009 102 111
8. M.G. Butler, S. Isogai, and B.M. Weinstein Lymphatic development Birth Defects Res C Embryo Today 87 2009 222 231
9. K. Yaniv, S. Isogai, and D. Castranova Live imaging of lymphatic development in the zebrafish Nat Med 12 2006 711 716 (Pubitemid 43865243)
10. A.M. Kuchler, E. Gjini, and J. Peterson-Maduro Development of the zebrafish lymphatic system requires VEGFC signaling Curr Biol 16 2006 1244 1248 (Pubitemid 43867297)
11. R.S. Srinivasan, X. Geng, and Y. Yang The nuclear hormone receptor Coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells Genes Dev 24 2010 696 707
12. I. Geudens, R. Herpers, and K. Hermans Role of delta-like-4/Notch in the formation and wiring of the lymphatic network in zebrafish Arterioscler Thromb Vasc Biol 30 2010 1695 1702
13. B.M. Hogan, R. Herpers, and M. Witte Vegfc/Flt4 signalling is suppressed by Dll4 in developing zebrafish intersegmental arteries Development 136 2009 4001 4009
14. M. Westerfield The zebrafish book. Guide for the laboratory use of zebrafish (Danio rerio). Eugene 1995 Univ. of Oregon Press Eugene
15. N.D. Lawson, and B.M. Weinstein In vivo imaging of embryonic vascular development using transgenic zebrafish Dev Biol 248 2002 307 318 (Pubitemid 35002091)
16. S. Isogai, M. Horiguchi, and B.M. Weinstein The vascular anatomy of the developing zebrafish: an atlas of embryonic and early larval development Dev Biol 230 2001 278 301 (Pubitemid 32171423)
17. S. Isogai, N.D. Lawson, and S. Torrealday Angiogenic network formation in the developing vertebrate trunk Development 130 2003 5281 5290 (Pubitemid 37369685)
18. D.J. Dumont, L. Jussila, and J. Taipale Cardiovascular failure in mouse embryos deficient in VEGF receptor-3 Science 282 1998 946 949 (Pubitemid 28507528)
19. K. Taniguchi, R. Kohno, and T. Ayada Spreds are essential for embryonic lymphangiogenesis by regulating vascular endothelial growth factor receptor 3 signaling Mol Cell Biol 27 2007 4541 4550 (Pubitemid 46906575)
20. L.F. Allen, J. Sebolt-Leopold, and M.B. Meyer CI-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK) Semin Oncol 30 2003 105 116 (Pubitemid 37433401)
21. J.F. Ohren, H. Chen, and A. Pavlovsky Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition Nat Struct Mol Biol 11 2004 1192 1197
22. R.E. Bolcome III, and J. Chan Constitutive MEK1 activation rescues anthrax lethal toxin-induced vascular effects in vivo Infect Immun 78 2010 5043 5053
23. R.E. Bolcome III, S.E. Sullivan, and R. Zeller Anthrax lethal toxin induces cell death-independent permeability in zebrafish vasculature Proc Natl Acad Sci U S A 105 2008 2439 2444 (Pubitemid 351520532)
24. F. Zhou, Z. Chang, and L. Zhang Akt/protein kinase B is required for lymphatic network formation, remodeling, and valve development Am J Pathol 2010
25. C.R. Schnell, F. Stauffer, and P.R. Allegrini Effects of the dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 on the tumor vasculature: implications for clinical imaging Cancer Res 68 2008 6598 6607
26. V. Serra, B. Markman, and M. Scaltriti NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations Cancer Res 68 2008 8022 8030
27. J.M. Wood, G. Bold, and E. Buchdunger PTK788/ZK 222584, a novel and potent inhibitor of vasular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration Cancer Res 60 2000 2178 2189 (Pubitemid 30225181)
28. P. Carmeliet Angiogenesis in life, disease and medicine Nature 438 2005 932 936 (Pubitemid 43093958)
29. P. Haiko, T. Makinen, and S. Keskitalo Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos Mol Cell Biol 8 2008 4843 4850
30. M.J. Karkkainen, A. Saaristo, and L. Jussila A model for gene therapy of human hereditary lymphedema Proc Natl Acad Sci U S A 98 2001 12677 12682 (Pubitemid 33020005)
31. A. Ghalamkarpour, W. Holnthoner, and P. Saharinen Recessive primary congenital lymphoedema caused by a VEGFR3 mutation J Med Genet 2009
32. R.H. Mellor, C.E. Hubert, and A.W. Stanton Lymphatic dysfunction, not aplasia, underlies Milroy disease Microcirculation 17 2010 281 296
33. A.J. Cochran, S. Binder, and D.L. Morton The role of lymphatic mapping and sentinel node biopsy in the management of atypical and anomalous melanocytic lesions J Cutan Pathol 37 2010 54 59
34. J. Chan, P.E. Bayliss, and J.M. Wood Dissection of angiogenic signaling in zebrafish using a chemical genetic approach Cancer Cell 1 2002 257 267 (Pubitemid 41039150)
35. P.E. Bayliss, K.L. Bellavance, and G.G. Whitehead Chemical modulation of receptor signaling inhibits regenerative angiogenesis in adult zebrafish Nat Chem Biol 2 2006 265 273
36. H. Davies, G.R. Bignell, and C. Cox Mutations of the BRAF gene in human cancer Nature 417 2002 949 954 (Pubitemid 34716871)
37. E. Tokunaga, E. Oki, and A. Egashira Deregulation of the Akt pathway in human cancer Curr Cancer Drug Targets 8 2008 27 36 (Pubitemid 351237907)
38. J.A. Engelman, L. Chen, and X. Tan Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers Nat Med 14 2008 1351 1356